Data / Form D filings / Hanimune Therapeutics Inc
Hanimune Therapeutics Inc: Form D filings
Hanimune Therapeutics Inc, an agriculture company in Philadelphia, PA, filed 6 Form D notices with the SEC between 2019 and 2023. The latest, on February 7, 2023, reports $3.3 million sold of a $5.1 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1711 NORTH HOWARD STREET, Philadelphia, PA, 19122
- Phone
- (484) 816-6467
- Industry
- Agriculture
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1769072
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 7, 2023 | New notice | $5,064,275 | $3,304,288 | $1,759,987 | 33 | Jan 24, 2023 | sec.gov |
| Mar 10, 2021 | New notice | $759,360 | $759,360 | 16 | Feb 25, 2021 | sec.gov | |
| Nov 25, 2019 | New notice | Indefinite | $0 | 1 | Sep 16, 2019 | sec.gov | |
| Nov 22, 2019 | Amendment | $1,000,000 | $680,000 | $320,000 | 14 | Jan 25, 2019 | sec.gov |
| Apr 26, 2019 | Amendment | $580,000 | $580,000 | 13 | Jan 25, 2019 | sec.gov | |
| Feb 26, 2019 | New notice | $530,000 | $530,000 | 11 | Jan 25, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Meenal Lele | Executive Officer, Director | |
| Hany Michail | Director |
Every Form D from the week of Feb 6, 2023 · All recent filings in Pennsylvania · All recent Agriculture filings
Read from SEC EDGAR. Amount sold is what Hanimune Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.